ESPREsperion Therapeutics Inc.
ESPR
Esperion Therapeutics Inc.9,357
Mkt Cap
$894.32MVolume
3.04M52W High
$4.1352W Low
$0.6925PE Ratio
-6.81ESPR Fundamentals
Price
$3.65Prev Close
$3.71Open
$3.7450D MA
$3.13Beta
1.09Avg. Volume
7.49MEPS (Annual)
-$0.2764P/B
-1.66Rev/Employee
$1.09MEsperion Therapeutics (NASDAQ:ESPR) Sets New 12-Month High - Should You Buy?
Esperion Therapeutics (NASDAQ:ESPR) Hits New 12-Month High - Here's Why...
MarketBeat·5d ago
Two Seas Capital LP Raises Holdings in Esperion Therapeutics, Inc. $ESPR
Two Seas Capital LP raised its position in shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) by 43.6% in the second quarter, according to the company in its most recent Form 13F...
MarketBeat·13d ago
Esperion Therapeutics (NASDAQ:ESPR) Hits New 52-Week High - Should You Buy?
Esperion Therapeutics (NASDAQ:ESPR) Hits New 1-Year High - Should You Buy...
MarketBeat·20d ago
Esperion Therapeutics (NASDAQ:ESPR) Trading 6% Higher - Here's What Happened
Esperion Therapeutics (NASDAQ:ESPR) Shares Up 6% - What's Next...
MarketBeat·21d ago
Traders Purchase Large Volume of Call Options on Esperion Therapeutics (NASDAQ:ESPR)
Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) was the target of unusually large options trading activity on Tuesday. Stock traders acquired 4,601 call options on the stock. This...
MarketBeat·22d ago
Esperion Therapeutics (NASDAQ:ESPR) Coverage Initiated at Piper Sandler
Piper Sandler assumed coverage on Esperion Therapeutics in a report on Tuesday. They set an "overweight" rating and a $9.00 target price on the stock...
MarketBeat·22d ago
Esperion Therapeutics (NASDAQ:ESPR) Trading Up 4.1% - Should You Buy?
Esperion Therapeutics (NASDAQ:ESPR) Shares Up 4.1% - Still a Buy...
MarketBeat·26d ago
Esperion Partner HLS Receives Health Canada Approval For NILEMDO To Lower LDL-Cholesterol
(RTTNews) - Esperion Therapeutics, Inc. (ESPR) on Tuesday said HLS Therapeutics Inc. (HLS), its partner in Canada for NILEMDO, has received Health Canada approval to market NILEMDO for reducing...
Nasdaq News: Markets·30d ago
HC Wainwright Has Positive Outlook for ESPR FY2025 Earnings
Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) - HC Wainwright increased their FY2025 earnings estimates for shares of Esperion Therapeutics in a note issued to investors on Thursday...
MarketBeat·1mo ago
<
1
2
...
>